Literature DB >> 27139824

Co-crystal structures of the protein kinase haspin with bisubstrate inhibitors.

Darja Lavogina1, Katrin Kestav1, Apirat Chaikuad2, Christina Heroven2, Stefan Knapp2, Asko Uri1.   

Abstract

Haspin is a mitotic protein kinase that is responsible for the phosphorylation of Thr3 of histone H3, thereby creating a recognition motif for docking of the chromosomal passenger complex that is crucial for the progression of cell division. Here, two high-resolution models of haspin with previously reported inhibitors consisting of an ATP analogue and a histone H3(1-7) peptide analogue are presented. The structures of the complexes confirm the bisubstrate character of the inhibitors by revealing the signature binding modes of the moieties targeting the ATP-binding site and the protein substrate-binding site of the kinase. This is the first structural model of a bisubstrate inhibitor targeting haspin. The presented structural data represent a model for the future development of more specific haspin inhibitors.

Entities:  

Keywords:  bisubstrate; haspin; histone; inhibitor; linker; protein kinase

Mesh:

Substances:

Year:  2016        PMID: 27139824      PMCID: PMC4854560          DOI: 10.1107/S2053230X16004611

Source DB:  PubMed          Journal:  Acta Crystallogr F Struct Biol Commun        ISSN: 2053-230X            Impact factor:   1.056


  24 in total

Review 1.  The protein kinase complement of the human genome.

Authors:  G Manning; D B Whyte; R Martinez; T Hunter; S Sudarsanam
Journal:  Science       Date:  2002-12-06       Impact factor: 47.728

2.  Bisubstrate inhibitor approach for targeting mitotic kinase Haspin.

Authors:  Katrin Kestav; Darja Lavogina; Gerda Raidaru; Apirat Chaikuad; Stefan Knapp; Asko Uri
Journal:  Bioconjug Chem       Date:  2015-01-29       Impact factor: 4.774

3.  Histone H3 Thr-3 phosphorylation by Haspin positions Aurora B at centromeres in mitosis.

Authors:  Fangwei Wang; Jun Dai; John R Daum; Ewa Niedzialkowska; Budhaditya Banerjee; P Todd Stukenberg; Gary J Gorbsky; Jonathan M G Higgins
Journal:  Science       Date:  2010-08-12       Impact factor: 47.728

4.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

5.  Identification of small molecule inhibitors of the mitotic kinase haspin by high-throughput screening using a homogeneous time-resolved fluorescence resonance energy transfer assay.

Authors:  Debasis Patnaik; Marcie A Glicksman; Gregory D Cuny; Ross L Stein; Jonathan M G Higgins
Journal:  J Biomol Screen       Date:  2008-10-31

Review 6.  Scaling and assessment of data quality.

Authors:  Philip Evans
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2005-12-14

Review 7.  Pseudokinases-remnants of evolution or key allosteric regulators?

Authors:  Elton Zeqiraj; Daan M F van Aalten
Journal:  Curr Opin Struct Biol       Date:  2010-11-10       Impact factor: 6.809

8.  MolProbity: all-atom structure validation for macromolecular crystallography.

Authors:  Vincent B Chen; W Bryan Arendall; Jeffrey J Headd; Daniel A Keedy; Robert M Immormino; Gary J Kapral; Laura W Murray; Jane S Richardson; David C Richardson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-12-21

9.  Quantitative network mapping of the human kinome interactome reveals new clues for rational kinase inhibitor discovery and individualized cancer therapy.

Authors:  Feixiong Cheng; Peilin Jia; Quan Wang; Zhongming Zhao
Journal:  Oncotarget       Date:  2014-06-15

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.